Jim Simons Axogen, Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Axogen, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 142,000 shares of AXGN stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142,000
Previous 62,000
129.03%
Holding current value
$2.31 Million
Previous $1.15 Million
34.26%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AXGN
# of Institutions
172Shares Held
40.5MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$73.8 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$44.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$40.9 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$31.5 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $689M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...